209 related articles for article (PubMed ID: 7777765)
1. [Metastatic cancer of the prostate: course, diagnosis and therapeutic management].
Wisard M; Gabellon S
Rev Med Suisse Romande; 1995 Mar; 115(3):241-7. PubMed ID: 7777765
[No Abstract] [Full Text] [Related]
2. The treatment of hormone refractory prostate cancer.
Panvichian R; Pienta KJ
Compr Ther; 1996 Feb; 22(2):81-7. PubMed ID: 8689867
[No Abstract] [Full Text] [Related]
3. A comparison of the treatment of metastatic prostate cancer by testicular ablation or total androgen blockade. The Canadian Anandron Study Group.
Cancer Treat Res; 1992; 59():29-40. PubMed ID: 1347692
[No Abstract] [Full Text] [Related]
4. Prostatic cancer--what to do? Staging and prognostic factors in the primary therapy decision.
Faul P
Eur Urol; 1992; 22(2):89-98. PubMed ID: 1478236
[No Abstract] [Full Text] [Related]
5. [What is safe in the therapy of advanced prostatic cancer?].
Gropp C; Burk K
Internist (Berl); 1985 Dec; 26(12):765-70. PubMed ID: 3936819
[No Abstract] [Full Text] [Related]
6. Cytology of metastatic prostate cancer following orchiectomy and antiandrogen therapy: a diagnostic challenge.
Rapkiewicz A; Gorokhovsky R; Farcon E; Das K
Diagn Cytopathol; 2008 Jul; 36(7):499-502. PubMed ID: 18528888
[TBL] [Abstract][Full Text] [Related]
7. Paradigms in androgen/castrate resistant states of prostate cancer in a biomarker era.
Bianco FJ
Urol Oncol; 2008; 26(4):408-14. PubMed ID: 18593619
[TBL] [Abstract][Full Text] [Related]
8. Complete androgen blockade for metastatic prostate cancer.
Presti JC
West J Med; 1994 Feb; 160(2):169-70. PubMed ID: 8160471
[No Abstract] [Full Text] [Related]
9. [Complete androgen blockage in the treatment of metastatic prostate cancer].
Matzkin H; Braf Z
Harefuah; 1994 Mar; 126(5):260-3. PubMed ID: 8188104
[No Abstract] [Full Text] [Related]
10. Continued targeting of androgen receptor signalling: a rational and efficacious therapeutic strategy in metastatic castration-resistant prostate cancer.
Bianchini D; de Bono JS
Eur J Cancer; 2011 Sep; 47 Suppl 3():S189-94. PubMed ID: 21943974
[No Abstract] [Full Text] [Related]
11. The role of endocrine therapy in the management of local and distant recurrence of prostate cancer following radical prostatectomy or radiation therapy.
Mayer FJ; Crawford ED
Urol Clin North Am; 1994 Nov; 21(4):707-15. PubMed ID: 7974899
[TBL] [Abstract][Full Text] [Related]
12. Treatment options in androgen-independent prostate cancer.
Lara PN; Meyers FJ
Cancer Invest; 1999; 17(2):137-44. PubMed ID: 10071598
[TBL] [Abstract][Full Text] [Related]
13. Systemic therapeutic strategies for prostate cancer.
Nelson WG
Clin Adv Hematol Oncol; 2005 Aug; 3(8):619-21. PubMed ID: 16167046
[No Abstract] [Full Text] [Related]
14. Caring for a patient with metastatic prostate cancer.
Held-Warmkessel J
Nursing; 2008 Jun; 38(6):52-6. PubMed ID: 18497662
[TBL] [Abstract][Full Text] [Related]
15. [Review of phase III clinical trials on combined anti-androgen therapies in patients with metastasized prostatic cancer].
Denis L; Dalesio O; Murphy G
Prog Urol; 1993 Feb; 3(1):75-85. PubMed ID: 8485599
[No Abstract] [Full Text] [Related]
16. [Treatment of advanced prostate cancer].
Leisinger HJ; Jichlinski P
Rev Med Suisse Romande; 1999 Jun; 119(6):507-11. PubMed ID: 10422478
[No Abstract] [Full Text] [Related]
17. Prostatectomy or watchful waiting in prostate cancer.
Coen JJ; Zietman AL; Shipley WU
N Engl J Med; 2003 Jan; 348(2):170-1; author reply 170-1. PubMed ID: 12523306
[No Abstract] [Full Text] [Related]
18. New agents in metastatic prostate cancer.
Fizazi K; Massard C
Eur J Cancer; 2009 Sep; 45 Suppl 1():379-80. PubMed ID: 19775638
[No Abstract] [Full Text] [Related]
19. Overview of current status of total androgen deprivation in metastasized prostate cancer.
Debruyne FM; Witjes WP
Eur Urol; 1993; 24 Suppl 2():67-71. PubMed ID: 8262129
[TBL] [Abstract][Full Text] [Related]
20. Update of EORTC clinical trials in prostate cancer. The EORTC Genito-Urinary Group.
Newling DW; Pavone Macaluse M; Smith P; de Voogt HJ; Robinson MR; Schroder FH; Denis L; Jones WG; de Pauw M; Sylvester R
Semin Urol; 1992 Feb; 10(1):65-71. PubMed ID: 1565905
[No Abstract] [Full Text] [Related]
[Next] [New Search]
